E-submission
Search
- Page Path
- HOME > Search
Newsletter
- What’s new in hematopathology 2025: myeloid neoplasms in the WHO 5th edition and ICC
- Barina Aqil
- J Pathol Transl Med. 2025;59(6):472-475. Published online October 22, 2025
- DOI: https://doi.org/10.4132/jptm.2025.09.24
- 10,698 View
- 379 Download
- 1 Web of Science
- 1 Crossref
-
Abstract
PDF - The previous edition of the World Health Organization (WHO) classification of hematolymphoid neoplasms was published in 2008 and later revised in 2017. A new 5th edition of the WHO classification of hematolymphoid neoplasms was released in 2022. Additionally, the Clinical Advisory Committee developed the International Consensus Classification (ICC) of hematolymphoid tumors, which differs from the WHO classification in several key defining features as outlined below.
-
Citations
Citations to this article as recorded by
- Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
Colette Hanna, Joe Rizkallah, Nicole Charbel, Shereen Sakkal, Fadi G. Haddad
Current Hematologic Malignancy Reports.2026;[Epub] CrossRef
- Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
First
Prev
